Additional File 5 - STD-Associated Symptoms and Treatment Status in MSM

Additional file 5 - STD-associated symptoms and treatment status in MSM

Variable HIV (+) HIV (-) Total p-value〒 N=81 (%) N=1,012 (%) N=1,093 (%) n (%) n (%) n (%) Symptomatic (inguinal lymph node enlargement, ulceration in 0.268‡ exogenitalia, purulent urethral discharge) Yes 12/77 (15.6) 105/925 (11.4) 117/1001 (11.7) inguinal lymph node 2/12 (16.7) 12/103 (11.7) 14/115 (12.2) 0.608‡ enlargement ulceration in 3/12 (25.0) 40/103 (38.8) 43/115 (37.4) 0.375‡ exogenitalia purulent urethral 9/12 (75.0) 53/103 (51.5) 62/115 (53.9) 0.135‡ discharge Other STD (syphilis, gonorrhea, condyloma) 0.225‡ Yes 19/77 (24.7) 172/926 (18.6) 191/1003 (19.0) Syphilis 6/19 (31.6) 26/171 (15.2) 32/190 (16.8) 0.098‡ Gonorrhea 4/19 (21.1) 38/171 (22.2) 42/190 (22.1) 0.943‡ Condyloma 2/19 (10.5) 42/171 (24.6) 44/190 (23.2) 0.173‡ Unknown 7/19 (36.8) 65/171 (38.0) 72/190 (37.9) 0.921 STD treatment completed <0.001 Yes 17/19 (89.5) 158/188 (79.4) 175/207 (84.5) Syphilis test <0.001‡ Positive 16/81 (19.8) 67/1012 (6.6) 83/1093 (7.6) 〒. Pearson Chi-Square. ‡. Fisher's Exact Test